Genetic High Cholesterol: It’s More Than Just Diet

• Many people believe that high cholesterol is caused solely by diet. In reality, genetics plays a significant role in determining an individual's cholesterol levels, particularly in people with Familial Hypercholesterolemia (FH).
• Some people with high blood cholesterol make efforts to modify their lifestyle and environmental factors but still do not see the expected improvement in their blood test results. This may indicate that they not only have genetic traits that contribute to high cholesterol, but may also have a gene mutation.
• Chronically high cholesterol can cause the arteries to harden and narrow, reducing blood flow to the heart. Therefore, treating high cholesterol is not only about lowering blood lipid levels, but also about reducing the future risk of coronary artery disease and myocardial infarction (heart attack). A Polygenic Risk Score (PRS) can help assess an individual's genetic tendencies, such as fat absorption, LDL clearance, and vascular inflammation. This information is converted into a risk score that estimates the future risk of developing coronary artery disease, helping doctors develop more precise prevention and treatment plans.

High cholesterol is a common health concern and an important risk factor for coronary artery disease and acute myocardial ischemia. Many people believe that it is caused solely by diet. In reality, genetics plays a significant role in determining an individual's cholesterol levels.

High cholesterol can result from multiple factors, most commonly a combination of:

• Genetic predisposition 
• Lifestyle and environmental factors 

These include diet, physical activity, body weight, stress, smoking, and other medical conditions.

Many people inherit genetic characteristics—genetic traits—that influence how their bodies process cholesterol. These traits may affect:

• Body shape and fat distribution 
• Intestinal absorption of dietary fat 
• Cholesterol metabolism in the liver 
• Clearance of cholesterol from the bloodstream 
• Vascular inflammation 

These inherited tendencies often run in families but are not considered a single-gene inherited disorder. Family members may share similar risks, yet each person’s cholesterol profile is still influenced by lifestyle and environmental factors.

For most individuals with elevated cholesterol, the condition develops through the interaction between these genetic traits and lifestyle habits over time.

In approximately 1 in 300 individuals, high cholesterol is caused by a mutation in a single gene responsible for removing LDL cholesterol (“bad cholesterol”) from the body. This condition is known as Familial Hypercholesterolemia (FH).

FH is an inherited disorder characterized by markedly elevated LDL cholesterol levels from an early age, resulting in a substantially increased risk of premature coronary artery disease.

Key Features of FH

• Inherited in an autosomal dominant pattern — meaning you only need to inherit the gene from one parent to have the condition 
• Each child of an affected parent has a 50% chance of inheriting it
• LDL cholesterol is significantly elevated from childhood or early adulthood 
• Increased risk of early-onset heart disease 

“Premature” coronary artery disease generally refers to:

• Men younger than 55 years 
• Women younger than 60 years 

In the most severe scenario, when both parents have FH, there is a 25% chance that a child may inherit two abnormal copies of the gene. This severe form can lead to aggressive cardiovascular disease during childhood or adolescence.

The Real Concern: Cardiovascular Disease

• The ultimate concern in managing high cholesterol is not merely achieving a target cholesterol number, but preventing cardiovascular complications such as:
• Coronary artery disease 
• Heart attack 
• Stroke 
• Sudden cardiac death 

Therefore, every individual with elevated cholesterol should undergo a comprehensive cardiovascular risk assessment.

Genetic Traits and Cholesterol

Many people inherit genetic characteristics—genetic traits—that influence how their bodies process cholesterol. These traits may affect:

• Body shape and fat distribution 
• Intestinal absorption of dietary fat 
• Cholesterol metabolism in the liver 
• Clearance of cholesterol from the bloodstream 
• Vascular inflammation 

These inherited tendencies often run in families but are not considered a single-gene inherited disorder. Family members may share similar risks, yet each person’s cholesterol profile is still influenced by lifestyle and environmental factors.

For most individuals with elevated cholesterol, the condition develops through the interaction between these genetic traits and lifestyle habits over time.

In approximately 1 in 300 individuals, high cholesterol is caused by a mutation in a single gene responsible for removing LDL cholesterol (“bad cholesterol”) from the body. This condition is known as Familial Hypercholesterolemia (FH).

FH is an inherited disorder characterized by markedly elevated LDL cholesterol levels from an early age, resulting in a substantially increased risk of premature coronary artery disease.

Key Features of FH

• Inherited in an autosomal dominant pattern — meaning you only need to inherit the gene from one parent to have the condition 
• Each child of an affected parent has a 50% chance of inheriting it
• LDL cholesterol is significantly elevated from childhood or early adulthood 
• Increased risk of early-onset heart disease 

“Premature” coronary artery disease generally refers to:

• Men younger than 55 years 
• Women younger than 60 years 

In the most severe scenario, when both parents have FH, there is a 25% chance that a child may inherit two abnormal copies of the gene. This severe form can lead to aggressive cardiovascular disease during childhood or adolescence.

The Real Concern: Cardiovascular Disease
The ultimate concern in managing high cholesterol is not merely achieving a target cholesterol number, but preventing cardiovascular complications such as:

• Coronary artery disease 
• Heart attack 
• Stroke 
• Sudden cardiac death 

Therefore, every individual with elevated cholesterol should undergo a comprehensive cardiovascular risk assessment.

Modern cholesterol management focuses on individualized cardiovascular risk rather than cholesterol levels alone.

High-Risk Individuals: Patients with a predicted 10-year cardiovascular risk of 10% or greater, as determined by the PREVENT-ASCVD score, are considered high risk. 

1. Management typically includes:
   • Intensive lipid-lowering therapy 
   • Possible use of multiple cholesterol-lowering medications 
   • Strict lifestyle modification 
   • Evaluation for Familial Hypercholesterolemia 
   • Close cardiovascular monitoring 
2. Moderate-Risk Individuals: Patients with a predicted 10-year cardiovascular risk between 5% and 10%, as determined by the PREVENT-ASCVD score, are considered moderate risk. 
   • Management focuses on:
   • Dietary modification 
   • Weight control 
   • Regular exercise 
   • Smoking cessation 
   • Consideration of medication based on additional conditions such as diabetes or hypertension 
3. Lower-Risk Individuals: Patients with a predicted 10-year cardiovascular risk of less than 3%*, as determined by the PREVENT-ASCVD score, should focus primarily on preventive strategies, including:
   • Healthy nutrition 
   • Regular physical activity 
   • Adequate sleep 
   • Stress reduction 
   • Avoidance of smoking 
     (*A cardiovascular risk of 3-5% is considered borderline risk.)

Cardiovascular risk assessment today extends far beyond standard cholesterol testing.

1. Clinical Assessment
   Physicians consider:
   • Age and sex 
   • Blood pressure 
   • Smoking status 
   • Body weight and waist circumference 
   • Family history of heart disease 
2. Blood Lipid Testing
   Routine lipid evaluation includes:
   • Total cholesterol 
   • LDL cholesterol 
   • HDL cholesterol 
   • Triglycerides 
3. Advanced Biomarkers
   Additional biomarkers may provide more refined risk prediction, including:
   • hsCRP 
   • Lipoprotein(a) 
   • ApoB 
     ​​​​​​​These markers help assess vascular inflammation and atherosclerotic risk more precisely.
4. Genetic Risk Assessment
   Advances in genomic medicine now allow the evaluation of inherited cardiovascular susceptibility through polygenic risk scores (PRS).
   ​​​​​​​Unlike diagnostic tests for single-gene disorders like FH, PRS analyzes multiple genetic variants associated with:
5. Cholesterol metabolism 
   • Lipid absorption 
   • Vascular inflammation 
   • Cardiovascular susceptibility 
   • Other cardiovascular risk factors
     This approach provides a more personalized understanding of cardiovascular risk and may help guide earlier and more targeted prevention strategies.
6. Genome sequencing 
   Genome sequencing of the LDLR, APOB, and PCSK9 genes is recommended for individuals at the highest risk, particularly those suspected of having a genetic mutation or familial hypercholesterolemia (FH).
   

High cholesterol is not simply the result of poor diet or lifestyle choices. Genetics can substantially influence how the body handles cholesterol and how early cardiovascular disease may develop.

Understanding both inherited risk and environmental factors allows physicians to develop more personalized prevention and treatment strategies. Early identification of high-risk individuals — especially those with Familial Hypercholesterolemia — can significantly reduce the likelihood of premature heart disease and improve long-term cardiovascular outcomes.

At Samitivej Hospital in Bangkok, Thailand, we provide comprehensive cardiovascular risk assessment services for patients with hypercholesterolemia, including clinical risk factor evaluation, polygenic risk scores, and assessment of inherited lipid disorders. Our cardiovascular and genetic assessment services are provided through collaboration between the Clinical Genetics Service and the Cardiology Service.
Heart Center 
Genomics and Lifestyle Wellness Center